ArticleInternational journal of molecular sciences2022

Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer.

Valentina Doldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.